Dosage and administration
DIRECTIONS TWIST OFF TAB COMPLETELY TO OPEN. INSTILL 1 TO 2 DROPS IN THE AFFECTED EYE(S) AS NEEDED. DISCARD DROPPER AND DO NOT REUSE.
DIRECTIONS TWIST OFF TAB COMPLETELY TO OPEN. INSTILL 1 TO 2 DROPS IN THE AFFECTED EYE(S) AS NEEDED. DISCARD DROPPER AND DO NOT REUSE.
POVIDONE 0.6%
POLYVINYL ALCOHOL 1.4%
EYE LUBRICANT
KEEP OUT OF REACH OF CHILDREN. IF SWALLOWED, GET MEDICAL HELP OR CONTACT A POISON CONTROL CENTER RIGHT AWAY.
USES FOR TEMPORARY RELIEF OF BURNING AND IRRITATION DUE TO DRYNESS OF THE EYE
FOR USE AS A PROTECTANT AGAINST FURTHER IRRITATION OR TO RELIEVE DRYNESS OF THE EYE
WARNINGS DO NOT USE IF THE SINGLE-DOSE DROPPER IS NOT INTACT. TO AVOID CONTAMINATION, DO NOT TOUCH TIP OF DROPPER TO ANY SURFACE. ONCE OPENED, DISCARD.
IF YOU EXPERIENCE EYE PAIN, CHANGES IN VISION, CONTINUED REDNESS OR IRRITATION OF THE EYE, OR IF THE CONDITIONS WORSENS OR PERSISTS FOR MORE THAN 72 HOURS, DISCONTINUE USE AND CONSULT A DOCTOR. IF SOLUTION CHANGES COLOR OR BECOMES CLOUDY, DO NOT USE
OTHER INFORMATION STORE AT ROOM TEMPERATURE 15-30 DEGREES C (59-86 DEGREES F)
DIRECTIONS TWIST OFF TAB COMPLETELY TO OPEN. INSTILL 1 TO 2 DROPS IN THE AFFECTED EYE(S) AS NEEDED. DISCARD DROPPER AND DO NOT REUSE.
SODIUM CHLORIDE, WATER (PURIFIED)
QUESTIONS OR COMMENTS? 800-968-6788
MINIDROPS LUBRICANT EYE DROPS DROPPER
INDIVIDUAL PACKAGE TO AVOID CROSS-CONTAMINATION FROM REPEATED USE
COMPACT MINI-SIZE EASY TO CARRY OPTICS MANUFACTURED FOR OPTICS LABORATORY INC.EL MONTE, CA 91731 USA MADE IN TAIWAN
STERILE PRESERVATIVE FREE USE ONLY IF SINGLE-USE DROPPER IS INTACT USE AS A PROTECTANT AGAINST FURTHER IRRITATION OR TO RELIEVE DRYNESS OF THE EYE PRESERVATIVE-FREE FORMULA SAFE FOR DAILY USE SINGLE-USE DROPPERS, CONVENIENT TO USE AND CARRY
MINIDROPS AND OPTIC LABORATORY ARE TRADEMARKS OF OPTIC LABORATORY INC
res
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1046287 | MiniDrops 1.4 % / 0.6 % Ophthalmic Solution | PSN | 9 |
| 359969 | polyvinyl alcohol 1.4 % / povidone 0.6 % Ophthalmic Solution | PSN | 9 |
| 1046287 | polyvinyl alcohol 0.014 ML/ML / povidone 6 MG/ML Ophthalmic Solution [MiniDrops] | SBD | 9 |
| 359969 | polyvinyl alcohol 0.014 ML/ML / povidone 6 MG/ML Ophthalmic Solution | SCD | 9 |
| 1046287 | MiniDrops (polyvinyl alcohol 1.4 % / povidone 0.6 % ) Ophthalmic Solution | SY | 9 |
| 359969 | polyvinyl alcohol 1.4 % / povidone 0.6 % Ophthalmic Solution | SY | 9 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 64108-212-10 | MINIDROPS | 0.5 mL in 1 VIAL, SINGLE-USE | LIQUID | 0.5 | 9 | |
| 64108-212-12 | MINIDROPS | 30 in 1 BOX | LIQUID | 30 | 9 | |
| 64108-212-13 | MINIDROPS | 5 in 1 BOX | LIQUID | 5 | 9 | |
| 64108-212-65 | MINIDROPS | 65 in 1 BOX | LIQUID | 65 | 9 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 64108-212-12 | EA - Each | 64108-212 | 02c2830e-4730-414a-956e-31121c823bca | 1 | 2015-10-02 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| POLYVINYL ALCOHOL | ACTIVE INGREDIENT | 532B59J990 | 2 | |
| POVIDONE K30 | ACTIVE INGREDIENT | U725QWY32X | 2 | |
| POLYVINYL ALCOHOL | ACTIVE MOIETY | 532B59J990 | 2 | |
| POVIDONE K30 | ACTIVE MOIETY | U725QWY32X | 2 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 64108-212 | 64108-212-10, 64108-212-13, 64108-212-12, 64108-212-65 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SODIUM CHLORIDE | 451W47IQ8X | IACT |
| WATER | 059QF0KO0R | IACT |
| POVIDONE, UNSPECIFIED | FZ989GH94E | ACTIB |
| POLYVINYL ALCOHOL | 532B59J990 | ACTIB |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 8 | 2025-12-29 | monthly-update | 2026-06-03 17:46:49 |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION/ DROPS / OPHTHALMIC | 3 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / OPHTHALMIC | 10 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | GEL / OPHTHALMIC | 0.9 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | POWDER, FOR SOLUTION / OPHTHALMIC | 0.9 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / OPHTHALMIC | 55 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / OPHTHALMIC | 55 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | POWDER, FOR SOLUTION / OPHTHALMIC | 0.9 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / SUBCUTANEOUS | 0.7 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / NASAL | 7.4 mg/1ml | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION/ DROPS / OPHTHALMIC | 3 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / OPHTHALMIC | 10 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / SUBCUTANEOUS | 0.7 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / INTRAMUSCULAR | 17 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / OPHTHALMIC | 13 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / OPHTHALMIC | 55 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / OPHTHALMIC | 10 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / OPHTHALMIC | 13 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | GEL / OPHTHALMIC | 0.9 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | DROPS / OPHTHALMIC | 0.08 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | GEL / OPHTHALMIC | 0.9 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / INTRAMUSCULAR | 17 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | DROPS / OPHTHALMIC | 0.08 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | POWDER, FOR SOLUTION / OPHTHALMIC | 0.9 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION/ DROPS / OPHTHALMIC | 3 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / OPHTHALMIC | 13 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | DROPS / OPHTHALMIC | 0.08 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / INTRAVENOUS | 6320 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | DROPS / OPHTHALMIC | 0.08 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / SUBCUTANEOUS | 0.7 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / INTRAVENOUS | 6320 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / INTRAVENOUS | 6320 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / NASAL | 7.4 mg/1ml | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / INTRAVENOUS | 6320 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION/ DROPS / OPHTHALMIC | 3 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / INTRAVENOUS | 6320 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | GEL / OPHTHALMIC | 0.9 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / OPHTHALMIC | 10 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | POWDER, FOR SOLUTION / OPHTHALMIC | 0.9 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / OPHTHALMIC | 55 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / OPHTHALMIC | 13 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / NASAL | 7.4 mg/1ml | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / OPHTHALMIC | 55 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | GEL / OPHTHALMIC | 0.9 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | POWDER, FOR SOLUTION / OPHTHALMIC | 0.9 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / SUBCUTANEOUS | 0.7 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / NASAL | 7.4 mg/1ml | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / INTRAMUSCULAR | 17 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION/ DROPS / OPHTHALMIC | 3 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / INTRAMUSCULAR | 17 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / OPHTHALMIC | 13 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / SUBCUTANEOUS | 0.7 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / OPHTHALMIC | 10 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | DROPS / OPHTHALMIC | 0.08 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / NASAL | 7.4 mg/1ml | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / INTRAMUSCULAR | 17 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MINIDROPS | LUBRICANT EYE DROPS | Optics Laboratory, Inc | c13c5f91-50df-471c-a7c9-1747a2ac1250 | 2026-02-03 | Warnings | 64108-212-10 64108-212-13 64108-212-12 64108-212-65 64108-212 64108021210 64108021213 64108021212 64108021265 49f38ac7-54c3-3b87-e063-6294a90a65a5 c13c5f91-50df-471c-a7c9-1747a2ac1250 |
Adverse event summaries are temporarily unavailable. Other product information remains available.